Morning Overview on MSNOpinion

A once-a-day pill nearly doubled survival for patients with advanced pancreatic cancer in a 500-person trial

Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...

PATENT AWARDED FOR NOVEL CRYPTOGRAPHIC COMPUTATIONAL FUNCTIONS

An immense solution space that confounds QC and AI Modern cryptography assumes that mathematical expressions and ...
Morning Overview on MSN

An experimental drug doubled one-year survival for pancreatic cancer patients

Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...

Eledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation Transcript

Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...
InfoQ

AWS Introduces Workload Credentials Provider for Automated Certificate and Secret Management

AWS has recently announced the AWS Workload Credentials Provider to automatically deliver and refresh certificates and ...
Microsoft

Photo ZIP campaign targeting hospitality industry delivers Node.js implant for persistent access

Microsoft Threat Intelligence identified an active multi-stage intrusion campaign targeting hospitality organizations in ...